Amgen’s arthritis blockbuster Enbrel already owns an undesirable spot on the list of 10 drugs eligible for the first round of Medicare pricing negotiations. Now, the company is fighting back against a ...

May 17 (Reuters) - The U.S. Supreme Court on Monday dashed Novartis AG's (NOVN.S), opens new tab hopes of launching a generic version of Amgen Inc's (AMGN.O), opens new tab multibillion-dollar ...

A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state can reduce ...

Colorado became the first state in the country Friday to set a maximum price that insurers and patients can pay for a prescription medication — a move that’s likely to face lawsuits. The state’s ...

WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. On Monday, May 17 th, the U.S. Supreme Court decided not to take ...

Please provide your email address to receive an email when new articles are posted on . In 2026, Stelara will be discounted 66% from its list price for Medicare users, while Enbrel will be discounted ...

Health Canada has approved Merck's (NYSE:MRK) Brenzys (etanercept), a biosimilar to Amgen's (NASDAQ:AMGN) Enbrel, for the following new indications: Adult patients with chronic moderate to severe ...